You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

~ Buy the BYFAVO (remimazolam besylate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR BYFAVO


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for BYFAVO

Trial ID Title Status Sponsor Phase Start Date Summary
NCT05201300 ↗ Remimazolam and Propofol Anesthesia in Elderly Patients Not yet recruiting Ajou University School of Medicine N/A 2022-02-01 Remimazolam is a recently developed ultra-short agonist acting at the benzodiazepine binding site of the gamma-aminobutyric acid (GABA)A receptor. Remimazolam has a combination of the hemodynamic stability of benzodiazepines and the advantages of propofol, such as rapid onset, short duration of action, and improved controllability. A recent study showed that the efficacy of two induction doses of remimazolam (6 and 12 mg/kg/h) as a sedative for general anesthesia was not inferior to propofol (2.0-2.5 mg/kg), and hemodynamically more stable. On the other hand, a study on the emergence time and quality between propofol and remimazolam showed inconsistent results. The purpose of this study is to compare remimazolam to propofol on the intraoperative hemodynamic changes and recovery profiles, when used in combination with remifentanil in elderly patients undergoing general anesthesia.
NCT05412914 ↗ Remimazolam and Propofol on the Left Ventricular Strain During Anesthesia Induction for Non-cardiac Surgery Not yet recruiting Konkuk University Medical Center Phase 4 2022-08-01 This study to compare the impacts of remimazolam or propofol on the left ventricular global longitudinal strain (LV-GLS) during anesthesia induction for non-cardiac surgery. LV-GLS is analyzed by using speckle tracking technique of transthoracic echocardiography.
NCT05835713 ↗ Total Intravenous Anesthesia for Rigid Bronchoscopy Using Remimazolam Not yet recruiting Samsung Medical Center N/A 2023-05-01 Rigid bronchoscopy usually requires deep general anesthesia, but the duration of the procedure is relatively short. Remimazolam, a recently developed anesthetics, showed faster recovery from anesthesia and stable hemodynamics compared to propofol, the most popular anesthetics. However, few studies have investigated the usefulness of remimazolam for rigid bronchoscopy. Therefore, the investigators compared the usefulness of propofol and remimazolam in total intravenous anesthesia for rigid bronchoscopy.
NCT05866315 ↗ The Effect of Remimazolam on Opioid Induced Hyperalgesia Recruiting Wonkwang University Hospital N/A 2023-05-19 The goal of this prospective, randomized, controlled study is to investigate the effect of remimazolam on opioid-induced hyperalgesia (OIH) in patients undergoing single port-laparoscopically assisted urologic surgery. The main question[s] it aims to answer are: - [The mechanical hyperalgesia threshold] - [Area of hyperalgesia around the surgical incision 24 h after surgery (cm^2)] In three groups: Group RHR (Remimazolam- High-dose Remifentanil), Group DHR (Desflurane-low-dose Remifentanil) or Group DLR (Control).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for BYFAVO

Condition Name

Condition Name for BYFAVO
Intervention Trials
Tracheal Stenosis 1
Endobronchial Mass 1
Hemodynamics 1
Hyperalgesia, Mechanical 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for BYFAVO
Intervention Trials
Hyperalgesia 1
Tracheal Stenosis 1
Respiratory Tract Diseases 1
Respiration Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for BYFAVO

Trials by Country

Trials by Country for BYFAVO
Location Trials
Korea, Republic of 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for BYFAVO

Clinical Trial Phase

Clinical Trial Phase for BYFAVO
Clinical Trial Phase Trials
Phase 4 1
N/A 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for BYFAVO
Clinical Trial Phase Trials
Not yet recruiting 3
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BYFAVO

Sponsor Name

Sponsor Name for BYFAVO
Sponsor Trials
Konkuk University Medical Center 1
Samsung Medical Center 1
Wonkwang University Hospital 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for BYFAVO
Sponsor Trials
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.